Gideon Capital Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-4,992	Closed	-$424K	–	353
2017 Q3	$424K	Buy	+4,992	New	+$424K	0.42%	68
2017 Q1	–	Sell	-6,071	Closed	-$385K	–	457
2016 Q4	$385K	Buy	+6,071	New	+$385K	0.25%	155